News

06/09/2024 | The Center for Ophthalmology at the University Hospital of Cologne has once again maintained its leading position in the field of corneal transplants in Germany in 2023.

04/09/2024 | Scientists at the University of Cologne, in collaboration with international partners, have developed a new experimental setup to induce sustained muscle contraction in nematodes using blue light alone.

03/09/2024 | Scientists at the University of Cologne have discovered that coordination between basic cellular processes is lost with increasing age / publication in ‘Nature Aging’

29/08/2024 | Follow-up funding for ophthalmology: Prof. Dr. Felix Bock (Cologne), together with Prof. Dr. Alexander Steinkasserer (Erlangen), has received follow-up funding from the German Research Foundation (DFG) for further research into donor-induced graft acceptance after corneal transplantation.

26/08/2024 | University of Cologne scientists have found that the protein histone H1.2 and the enzyme PARP1 could be potential therapeutic targets to decrease neurodegeneration in amyotrophic lateral sclerosis (ALS) / publication in ‘Cell Reports’

26/08/2024 | University of Cologne - New AI-based digital platform enables extremely fast and accurate analysis of tissue sections from lung cancer patients / publication in ‘Cell Reports Medicine’

20/08/2024 | Prof. Dr. Gereon R. Fink is honored as one of the most cited German neuroscientists for outstanding scientific achievements in the neurosciences.

31/07/2024 | The results of the new study could have significant implications for advancing our understanding of diabetes / publication in ‘Molecular Metabolism’

17/07/2024 | The Medical Faculty of the University of Cologne offers positions in the Cologne Clinician Scientist Program (CCSP), a training program for Clinician Scientists with a strong focus on translational and / or clinical research.

09/07/2024 | Together with other internationally renowned European scientists, the European Molecular Biology Organization (EMBO) has accepted the molecular biologist Professor Dr Aleksandra Trifunovic from the Institute of Mitochondrial Diseases and Ageing at the University of Cologne’s Faculty of Medicine, the CMMC Center for Molecular Medicine Cologne and the CECAD Cluster of Excellence for Aging Research as a new member.

10/06/2024 | The German Research Foundation (DFG) has approved a new Collaborative Research Center in mRNA research and extended funding for the CRC 1218 on mitochondria

07/06/2024 | A genetic disorder leads to an increase in bioactive lipids in the brain promoting mental disorders. New study shows that treatment with an enzyme inhibitor that prevents the activation of lipids can restore balance and alleviate symptoms.

29/05/2024 | The University of Cologne is holding events to promote equal opportunities - organized by the Vice Rectorate for Anti-Discrimination, Equal Opportunities and the Equal Opportunities Unit and cooporating partners.

17/05/2024 | The study highlights the importance of the integration of spatial and genetic data for the prediction of at-risk populations and the guidance of future research and policy. Publication in "Environ Health Perspect"

06/05/2024 | Two scientists from the University of Cologne have discovered that aging clocks are based on random events / publication in ‘Nature Aging’

30/04/2024 | We are pleased to extend our warmest congratulations to you on the occasion of your birthday. We recognize the dedication of your life to the pursuit of knowledge and scientific excellence.

26/04/2024 | The brain sends signals to the liver earlier than previously assumed, which then adapts the sugar metabolism - publication in ‘Science’.

11/04/2024 | Metabolism researcher Jens Brüning and geneticist Thorsten Hoppe, both working group leaders at the Cluster of Excellence for Aging Research CECAD and the Center for Molecular Medicine Cologne, receive European Research Council awards.

10/04/2024 | An international research team, led by PD Dr. Hajar Maleki (University of Cologne), has developed a novel approach to bone tissue engineering, that has the potential to significantly advance the restoration of damaged bone tissues in post-surgery osteosarcoma treatment.

08/04/2024 | New finding from scientists at the University of Cologne’s CECAD and CMMC discloses how mitochondria control tissue rejuvenation and synaptic plasticity in the adult mouse brain / publication in ‘Neuron’

08/04/2024 | After a 9-month certification process, four research groups at laboratory level 1 of the Center for Molecular Medicine Cologne (CMMC research building) have received the sustainability certificate awarded by the non-profit organization My Green Lab - with the highest certification level "Green". In the initial assessment, the CMMC research groups led by Dr. Hänsel-Hertsch, Dr. Simon Pöpsel, Dr. Debora Trentini and PD Dr. Catherin Niemann had already achieved bronze status.

18/03/2024 | Project involving the University of Cologne gives insights into a key brain function / publication in ‘Nature Neuroscience’

08/03/2024 | For the first time, scientists from the University of Cologne (UoC) have developed artificial nucleotides, the building blocks of DNA, with several additional properties in the laboratory. They could be used as artificial nucleic acids for therapeutic applications / publication in ‘Journal of the American Chemical Society’

07/03/2024 | Researchers from the University of Cologne (UoC) have discovered a regulatory mechanism that prevents an excessive and harmful immune response / publication in ‘Nature Communications’

16/02/2024 | Scientists at University Hospital Cologne have developed a procedure in the laboratory that effectively fights affected cells in lymphoma cancer without harming healthy immune cells, a common issue with comparable therapies / publication in ‘Cell Reports Medicine’

06/02/2024 | three scientists from Cologne - in recognition of their outstanding contributions to lung cancer diagnostics and therapy, specifically within the framework of the "National Network Genomic Medicine (nNGM) Lung Cancer", which they initiated.

01/02/2024 | DNA and RNA research is revolutionizing pharmaceutics: New drugs are being developed faster and at a lower cost, and they are effective against previously incurable diseases.

02/01/2024 | An international research team led by Jan Rybniker has identified several substances that have a dual effect against tuberculosis. These substances reduce the pathogenicity of the bacteria responsible for the disease in human immune cells and boost the activity of conventional antibiotics. The findings were published in 'Cell Chemical Biology'.

08/12/2023 | Cologne scientists decipher how the antibody response of our immune system reacts to a coronavirus infection and prepares for future infections / Publications in ‘Immunity’ and ‘Science Immunology’

06/12/2023 | With the € 1.1 Mio. Professorship Funding from Else Körner Foundation, Philipp Schommer is dedicated to further advance antiviral therapies and vaccines. Further information: Schommers Laboratory of Antiviral Immunity

29/11/2023 | The German research Foundation (DFG) has approved a Collaborative Research Centre (CRC) in the field of ophthalmology / CRCs on cell death and Arctic climate research are being further funded.

02/11/2023 | Broadly neutralizing antibodies are already being used to fight viruses. This approach could also help to treat infections with multi-resistant bacteria in the future / publication in the renowned journal ‘Cell’

26/10/2023 | The ERC BATPROJECT "Learning from Bats: New strategies to extend healthspan and improve diseases resistancce". European Research Council (ERC) is funding the project ‘BATPROTECT’ with 11.9 million euros over a period of six years

04/10/2023 | In planta expression of human polyQ-expanded huntingtin fragment reveals mechanisms to prevent disease-related protein aggregation/ new research reported in “Nature Aging” may have found a way to “copy” the mechanism for application in human cells

21/09/2023 | addressed these challenges and successfully contributed to intensify the interdisciplinary exchange. We were delighted to welcome over 320 participants.

27/07/2023 | University of Cologne Scientists discover that cleavage of the protein cFLIP is crucial to limit cell death and promote tissue regeneration / Publication in Science Advances

28/06/2023 | In this study, Cologne researchers demonstrate a differential expression of BTLA on renal immune cells during glomerulonephritis. indicating that the immune checkpoint molecule BTLA has great potential to restrain T-cell mediated kidney inflammation.

02/06/2023 | With deep sadness, we received the news of the loss of our dear friend and colleague Konstantin Belostotski.

26/05/2023 | Cologne researchers identify a novel chaperonopathy causing altered protein O-glycosylation. This discovery will promote a better understanding of the role of complex O-glycans in human health and disease.

22/05/2023 | With this extension, the members of the TRR 259 are excited to continue cutting-edge research into aortic diseases in Cologne, Düsseldorf, and Bonn.

22/05/2023 | Unmet medical needs, societal implications and future therapeutic perspectives.

08/05/2023 | To celebrate the start of the second funding period the FOR 2722 is hosting an International Symposium.

13/04/2023 | In a large joint study, researchers of the University of Cologne, the Cologne Max Planck Institute for Biology of Aging (MPI) and the University of Göttingen have shown that across the animal kingdom with increasing age, the transcriptional elongation speed of genes increases, whereby the quality of the gene products suffers and that with dietary restrictions, these processes could be reversed.

30/03/2023 | Researchers of the University of Cologne describe that the competence for the future cardiac fate of human embryonic stem cells (hESCs) is preset in pluripotency by a specialized mRNA translation circuit controlled by RBPMS l published in Science Advances

26/03/2023 | demonstrating that the DREAM complex functions as conserved master regulator of somatic DNA-repair capacities.

25/03/2023 | On March 23, 2023 she receives the national prize the "Duchenne-Erb Prize" in recognition of her life's work as a human geneticist and her outstanding scientific achievements: the elucidation of the genetic cause of spinal muscular atrophy (SMA), the discovery of genetic factors that protect against SMA and the associated cellular pathomechanisms.

23/03/2023 | The 14. Annual Congress of the Technology and Methods Platform for Networked Medical Research (TMF) will focus on the opportunities, risks and challenges of genomic medicine.